A pilot school-based health center intervention to improve asthma chronic care in high-poverty schools

Lucy C Holmes, Heather Orom, Heather K Lehman, Stacie Lampkin, Jill S Halterman, Vanessa Akiki, Alicia A Supernault-Sarker, Susan B Butler, Denise Piechowski, Patricia M Sorrentino, Ziqiang Chen, Gregory E Wilding, Lucy C Holmes, Heather Orom, Heather K Lehman, Stacie Lampkin, Jill S Halterman, Vanessa Akiki, Alicia A Supernault-Sarker, Susan B Butler, Denise Piechowski, Patricia M Sorrentino, Ziqiang Chen, Gregory E Wilding

Abstract

Objective: To test the feasibility and effectiveness of a multifaceted intervention administered through school-based health centers (SBHCs) to improve asthma control for children in high-poverty schools with not well controlled asthma.

Methods: Students 4-14 years old with persistent asthma were enrolled from three SBHCs. The centers' advanced practice providers received training on evidence-based asthma guidelines. Students randomized to the intervention received directly observed therapy of their asthma controller medication, medication adjustments as needed by the centers' providers, and daily self-management support. Students randomized to usual care were referred back to their primary care provider (PCP) for routine asthma care.

Results: We enrolled 29 students. Students in the intervention group received their controller medication 92% of days they were in school. Ninety-four percent of follow-up assessments were completed. During the study, 11 of 12 intervention students had a step-up in medication; 2 of 15 usual care students were stepped up by their PCP. Asthma Control Test scores did not differ between groups, although there were significant improvements from baseline to the 7 month follow-up within each group (both p < .01). Both FEV1% predicted and FEV1/FVC ratio significantly worsened in the usual care group (both p = .001), but did not change in the intervention group (p = .76 and .28 respectively).

Conclusions: Our pilot data suggest that a multifaceted intervention can be feasibly administered through SBHCs in communities with health disparities. Despite the small sample size, spirometry detected advantages in the intervention group. Further study is needed to optimize the intervention and evaluate outcomes.

Trial registration: clinicaltrials.gov Identifier: NCT03032744.

Keywords: Pediatrics; children; chronic care model; directly observed therapy; health disparities; health services research; medication adherence; national guidelines; prevention; pulmonary function test; spirometry; treatment.

Conflict of interest statement

Declaration of Interest: The authors report no conflicts of interest.

Figures

Figure 1:
Figure 1:
CONSORT FLOW DIAGRAM
Figure 2.
Figure 2.
Mean (95% CI) normalized ACT scores (combined ACT and C-ACT scores) based on a 4 week recall. Both groups significantly improved from baseline to 7 months (both p

Figure 3.

Mean (95% CI) number of…

Figure 3.

Mean (95% CI) number of days per week with daytime asthma symptoms in…

Figure 3.
Mean (95% CI) number of days per week with daytime asthma symptoms in the previous 4 weeks. Both groups significantly improved from baseline to 7 months (both p

Figure 4.

Mean (95% CI) number of…

Figure 4.

Mean (95% CI) number of nights per month with nighttime awakenings due to…

Figure 4.
Mean (95% CI) number of nights per month with nighttime awakenings due to asthma in the previous 4 weeks. Both groups significantly improved from baseline to 7 months (both p

Figure 5.

Spirometry. Mean (95% CI) FEV…

Figure 5.

Spirometry. Mean (95% CI) FEV 1 % predicted. FEV 1 % predicted significantly…

Figure 5.
Spirometry. Mean (95% CI) FEV1 % predicted. FEV1 % predicted significantly worsened in the usual care group from baseline to the 7 month follow-up (p=0.001), but did not change in the intervention group (p=0.76).

Figure 6.

Spirometry. Mean (95% CI) FEV…

Figure 6.

Spirometry. Mean (95% CI) FEV 1 /FVC ratio. FEV 1 /FVC ratio significantly…

Figure 6.
Spirometry. Mean (95% CI) FEV1/FVC ratio. FEV1/FVC ratio significantly worsened in the usual care group from baseline to the 7 month follow-up (p=0.001), but did not change in the intervention group (p=0.28).
Similar articles
Cited by
  • Updates in school-based asthma management.
    Lowe AA, Onge IS, Trivedi M. Lowe AA, et al. Curr Opin Allergy Clin Immunol. 2023 Apr 1;23(2):119-131. doi: 10.1097/ACI.0000000000000883. Epub 2022 Nov 24. Curr Opin Allergy Clin Immunol. 2023. PMID: 36730215 Review.
Publication types
Associated data
Related information
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Follow NCBI
Figure 3.
Figure 3.
Mean (95% CI) number of days per week with daytime asthma symptoms in the previous 4 weeks. Both groups significantly improved from baseline to 7 months (both p

Figure 4.

Mean (95% CI) number of…

Figure 4.

Mean (95% CI) number of nights per month with nighttime awakenings due to…

Figure 4.
Mean (95% CI) number of nights per month with nighttime awakenings due to asthma in the previous 4 weeks. Both groups significantly improved from baseline to 7 months (both p

Figure 5.

Spirometry. Mean (95% CI) FEV…

Figure 5.

Spirometry. Mean (95% CI) FEV 1 % predicted. FEV 1 % predicted significantly…

Figure 5.
Spirometry. Mean (95% CI) FEV1 % predicted. FEV1 % predicted significantly worsened in the usual care group from baseline to the 7 month follow-up (p=0.001), but did not change in the intervention group (p=0.76).

Figure 6.

Spirometry. Mean (95% CI) FEV…

Figure 6.

Spirometry. Mean (95% CI) FEV 1 /FVC ratio. FEV 1 /FVC ratio significantly…

Figure 6.
Spirometry. Mean (95% CI) FEV1/FVC ratio. FEV1/FVC ratio significantly worsened in the usual care group from baseline to the 7 month follow-up (p=0.001), but did not change in the intervention group (p=0.28).
Similar articles
Cited by
  • Updates in school-based asthma management.
    Lowe AA, Onge IS, Trivedi M. Lowe AA, et al. Curr Opin Allergy Clin Immunol. 2023 Apr 1;23(2):119-131. doi: 10.1097/ACI.0000000000000883. Epub 2022 Nov 24. Curr Opin Allergy Clin Immunol. 2023. PMID: 36730215 Review.
Publication types
Associated data
Related information
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 4.
Figure 4.
Mean (95% CI) number of nights per month with nighttime awakenings due to asthma in the previous 4 weeks. Both groups significantly improved from baseline to 7 months (both p

Figure 5.

Spirometry. Mean (95% CI) FEV…

Figure 5.

Spirometry. Mean (95% CI) FEV 1 % predicted. FEV 1 % predicted significantly…

Figure 5.
Spirometry. Mean (95% CI) FEV1 % predicted. FEV1 % predicted significantly worsened in the usual care group from baseline to the 7 month follow-up (p=0.001), but did not change in the intervention group (p=0.76).

Figure 6.

Spirometry. Mean (95% CI) FEV…

Figure 6.

Spirometry. Mean (95% CI) FEV 1 /FVC ratio. FEV 1 /FVC ratio significantly…

Figure 6.
Spirometry. Mean (95% CI) FEV1/FVC ratio. FEV1/FVC ratio significantly worsened in the usual care group from baseline to the 7 month follow-up (p=0.001), but did not change in the intervention group (p=0.28).
Figure 5.
Figure 5.
Spirometry. Mean (95% CI) FEV1 % predicted. FEV1 % predicted significantly worsened in the usual care group from baseline to the 7 month follow-up (p=0.001), but did not change in the intervention group (p=0.76).
Figure 6.
Figure 6.
Spirometry. Mean (95% CI) FEV1/FVC ratio. FEV1/FVC ratio significantly worsened in the usual care group from baseline to the 7 month follow-up (p=0.001), but did not change in the intervention group (p=0.28).

Source: PubMed

3
Se inscrever